186 related articles for article (PubMed ID: 1312901)
1. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Minniti CP; Maggi M; Helman LJ
Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
[TBL] [Abstract][Full Text] [Related]
2. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
3. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
El-Badry OM; Romanus JA; Helman LJ; Cooper MJ; Rechler MM; Israel MA
J Clin Invest; 1989 Sep; 84(3):829-39. PubMed ID: 2547840
[TBL] [Abstract][Full Text] [Related]
4. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ
Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
[TBL] [Abstract][Full Text] [Related]
9. Characterization of insulin-like growth factor receptors in the insulin-responsive R3230AC mammary adenocarcinoma.
Korc-Grodzicki B; Furlanetto RW; Hilf R
Oncol Res; 1992; 4(3):109-19. PubMed ID: 1377520
[TBL] [Abstract][Full Text] [Related]
10. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
12. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells.
Sullivan KA; Kim B; Buzdon M; Feldman EL
Brain Res; 1997 Jan; 744(2):199-206. PubMed ID: 9027379
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
Crouch GD; Helman LJ
Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-II stimulates steroidogenesis in cultured bovine thecal cells.
Spicer LJ; Voge JL; Allen DT
Mol Cell Endocrinol; 2004 Nov; 227(1-2):1-7. PubMed ID: 15501579
[TBL] [Abstract][Full Text] [Related]
15. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.
Fleck JF; Sledge GW; Benenati SV; Frolik CA; Roth BJ; Hirsch KS
Cancer Res; 1991 Aug; 51(16):4395-401. PubMed ID: 1678315
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
Myal Y; Shiu RP; Bhaumick B; Bala M
Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
Arteaga CL; Osborne CK
Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
[TBL] [Abstract][Full Text] [Related]
18. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
[TBL] [Abstract][Full Text] [Related]
19. Actions of insulin-like growth factor-I on the B104 neuronal cell line: effects on cell replication, receptor characteristics, and influence of secreted binding protein on ligand binding.
Orlowski CC; Chernausek SD; Akeson R
J Cell Physiol; 1989 Jun; 139(3):469-76. PubMed ID: 2544609
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.
Kalebic T; Tsokos M; Helman LJ
Cancer Res; 1994 Nov; 54(21):5531-4. PubMed ID: 7923191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
